Free Trial

Agios Pharmaceuticals (AGIO) Insider Trading & Ownership

Agios Pharmaceuticals logo
$27.71 -0.73 (-2.57%)
Closing price 04:00 PM Eastern
Extended Trading
$27.71 0.00 (0.00%)
As of 06:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agios Pharmaceuticals (NASDAQ:AGIO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.93%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$912,905.28
Get AGIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Agios Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AGIO Insider Buying and Selling by Quarter

Remove Ads

Agios Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/29/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Buy$33.73$1,001 - $15,000
1/6/2025Tsveta MilanovaInsiderSell2,804$32.18$90,232.72  
12/11/2024David ScaddenDirectorSell200$46.28$9,256.00  
9/26/2024Cecilia JonesCFOSell2,542$49.03$124,634.26  
8/8/2024Brian GoffCEOSell11,091$42.75$474,140.25  
4/10/2024Jacqualyn A FouseDirectorSell7,791$27.55$214,642.05  
(Data available from 1/1/2013 forward)

AGIO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Agios Pharmaceuticals includes Brian Goff, Cecilia Jones, David P Schenkein, David Scadden, Jacqualyn A Fouse, James William Burns, Kaye I Foster-Cheek, Sarah Gheuens, Theodore James Jr. Washburn, and Tsveta Milanova. Learn more on insiders at AGIO.

4.93% of Agios Pharmaceuticals stock is owned by insiders. Learn more on AGIO's insider holdings.

The following insiders have sold AGIO shares in the last 24 months: Brian Goff ($1,376,813.55), Cecilia Jones ($264,755.63), David P Schenkein ($373,894.55), David Scadden ($9,256.00), Jacqualyn A Fouse ($943,537.70), James William Burns ($366,219.55), Kaye I Foster-Cheek ($658,663.00), Sarah Gheuens ($16,139.88), Theodore James Jr. Washburn ($119,861.86), and Tsveta Milanova ($155,005.36).

Insiders have sold a total of 158,703 Agios Pharmaceuticals shares in the last 24 months for a total of $4,284,147.08 sold.

Gilbert Ray Cisneros, Jr. (D-CA) has bought shares of Agios Pharmaceuticals in the last year totaling $8,000.

Agios Pharmaceuticals Key Executives

  • Mr. Brian M. Goff M.B.A. (Age 55)
    CEO & Director
    Compensation: $1.23M
  • Ms. Cecilia JonesMs. Cecilia Jones (Age 49)
    Chief Financial Officer
    Compensation: $403.36k
  • Mr. James William BurnsMr. James William Burns (Age 46)
    Corporate Secretary & Chief Legal Officer
    Compensation: $660.33k
  • Dr. Sarah Gheuens M.D. (Age 44)
    Ph.D., Chief Medical Officer and Head of Research & Development
    Compensation: $769.2k
  • Dr. Lewis Clayton Cantley Ph.D. (Age 75)
    Co-Founder & Member of Scientific Advisory Board
    Compensation: $50k
  • Dr. Tak Wah Mak D.Sc. (Age 78)
    FRSC, Ph.D., Co-Founder & Member of Scientific Advisory Board
  • Dr. Craig B. Thompson M.D. (Age 71)
    Co-Founder & Chairman of Scientific Advisory Board
  • Dr. Shin-San Su Ph.D. (Age 68)
    Co-Founder & Member of Scientific Advisory Board
  • Mr. T. J. Washburn Jr. (Age 43)
    Principal Accounting Officer
  • Dr. Clive Patience Ph.D. (Age 60)
    Chief Technical Operations Officer


This page (NASDAQ:AGIO) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners